share_log

CVS Health | 4: Statement of changes in beneficial ownership of securities-Officer Mandadi Tilak

CVS Health | 4: Statement of changes in beneficial ownership of securities-Officer Mandadi Tilak

西維斯健康 | 4：持股變動聲明-高管 Mandadi Tilak
美股SEC公告 ·  09/04 05:51
牛牛AI助理已提取核心訊息
On August 31, 2024, CVS Health Corp's EVP and Chief Technology Officer, Mandadi Tilak, completed a sale of 13,097 shares of common stock at a price of $57.24 per share. The transaction, which was carried out under the transaction code 'F' indicating a payment of exercise price or tax liability by delivering or withholding securities, resulted in a total market value of $749,672.28. Following the sale, Tilak's direct holdings in CVS Health Corp amounted to 40,414 shares.
On August 31, 2024, CVS Health Corp's EVP and Chief Technology Officer, Mandadi Tilak, completed a sale of 13,097 shares of common stock at a price of $57.24 per share. The transaction, which was carried out under the transaction code 'F' indicating a payment of exercise price or tax liability by delivering or withholding securities, resulted in a total market value of $749,672.28. Following the sale, Tilak's direct holdings in CVS Health Corp amounted to 40,414 shares.
2024年8月31日，CVS Health Corp的執行副總裁兼首席技術官Mandadi Tilak以每股57.24美元的價格完成出售13,097股普通股的交易。該交易是在交易代碼「F」下進行的，表明通過交付或扣留證券支付行權價格或稅務責任，交易結果總市值爲749,672.28美元。在出售後，Tilak在CVS Health Corp的直接持股額爲40,414股。
2024年8月31日，CVS Health Corp的執行副總裁兼首席技術官Mandadi Tilak以每股57.24美元的價格完成出售13,097股普通股的交易。該交易是在交易代碼「F」下進行的，表明通過交付或扣留證券支付行權價格或稅務責任，交易結果總市值爲749,672.28美元。在出售後，Tilak在CVS Health Corp的直接持股額爲40,414股。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。